Furthermore, recent twin and family GWAS studies have identified LXRA and LXRB genes in signatures for coronary artery disease and hepatic steatosis, and have been interpreted to have broad effects on multiple metabolic traits (Rankinen et al., 2015). This evidence concerns the gene NR1H2 and fatty liver disease.